Method for preventing HIV-1 infection of CD4+ cells

Details for Australian Patent Application No. 2004233505 (hide)

Owner Progenics Pharmaceuticals, Inc.

Inventors Olson, William C.; Litwin, Virginia M.; Maddon, Paul J.; Allaway, Graham P.

Agent Davies Collison Cave

Pub. Number AU-A-2004233505

Parent 776239

Filing date 26 November 2004

Wipo publication date 23 December 2004

Acceptance publication date 21 February 2008

International Classifications

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

9 December 2004 Complete Application Filed

23 December 2004 Application Open to Public Inspection

  Published as AU-A-2004233505

21 February 2008 Application Accepted

  Published as AU-A-2004233505

19 June 2008 Standard Patent Sealed

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004233506-Piston pressure balancer for hot and cold water mixer valves

2004233504-Air-bubble-monitoring medication assembly, medical system and method